Centene Corporation

BOVESPA:C1NC34 Stock Report

Market Cap: R$168.1b

Centene Past Earnings Performance

Past criteria checks 4/6

Centene has been growing earnings at an average annual rate of 17.3%, while the Healthcare industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 13.3% per year. Centene's return on equity is 11.1%, and it has net margins of 2.1%.

Key information

17.3%

Earnings growth rate

14.4%

EPS growth rate

Healthcare Industry Growth11.6%
Revenue growth rate13.3%
Return on equity11.1%
Net Margin2.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Centene makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

BOVESPA:C1NC34 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24146,2043,06712,5070
30 Jun 24144,0642,82312,4550
31 Mar 24142,8002,73512,5730
31 Dec 23141,2662,70212,4070
30 Sep 23139,3642,44412,1300
30 Jun 23138,1112,71311,9340
31 Mar 23136,9411,48311,7040
31 Dec 22135,9991,20211,3660
30 Sep 22132,7562,01410,8920
30 Jun 22129,2281,86010,5620
31 Mar 22124,1811,4979,8880
31 Dec 21118,5731,3479,3760
30 Sep 21114,1307369,6570
30 Jun 21111,2847209,9950
31 Mar 21108,1582,46110,4610
31 Dec 20104,2801,80810,2760
30 Sep 2095,7642,0299,5290
30 Jun 2086,5231,5568,3010
31 Mar 2078,1058457,2900
31 Dec 1970,8071,3216,4480
30 Sep 1968,3851,3536,4720
30 Jun 1965,5071,2776,5910
31 Mar 1961,0281,0826,4570
31 Dec 1856,6889006,3310
30 Sep 1852,6188895,7950
30 Jun 1848,6551,0755,1050
31 Mar 1847,2011,0294,7970
31 Dec 1745,8108284,3700
30 Sep 1744,8708534,2670
30 Jun 1743,6467964,3030
31 Mar 1742,4687134,2460
31 Dec 1637,6935623,9000
30 Sep 1632,8394163,2840
30 Jun 1628,0623602,7190
31 Mar 1622,9482772,1520
31 Dec 1521,2923561,9900
30 Sep 1519,8543501,8270
30 Jun 1518,5483391,6990
31 Mar 1517,1022981,5640
31 Dec 1415,6892681,4240
30 Sep 1414,1342101,3000
30 Jun 1412,7001791,1830
31 Mar 1411,4751721,0550
31 Dec 1310,5441619310

Quality Earnings: C1NC34 has high quality earnings.

Growing Profit Margin: C1NC34's current net profit margins (2.1%) are higher than last year (1.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: C1NC34's earnings have grown by 17.3% per year over the past 5 years.

Accelerating Growth: C1NC34's earnings growth over the past year (25.5%) exceeds its 5-year average (17.3% per year).

Earnings vs Industry: C1NC34 earnings growth over the past year (25.5%) did not outperform the Healthcare industry 48.7%.

Return on Equity

High ROE: C1NC34's Return on Equity (11.1%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y